Table 3 Treatment information and outcomes
From: Fluoroquinolone resistance in bacteremic and low risk febrile neutropenic patients with cancer
Outcomes | No. | % |
|---|---|---|
Clinical deterioration | 11 | 29 |
Survival at day 30 | 36 | 94 |
Further infection | 11 | 29 |
Receiving G-CSF | 18 | 47 |
Antibiotic duration, days | Â | Â |
Median | 15 | |
Range | 9-35 | |
Fever duration, days | Â | Â |
Median | 4.3 | |
Range | 2-17 | |
Duration of hospitalization, days | Â | Â |
Median | 9.2 | |
Range | 5-28 | |
Oral treatments | Â | Â |
Ciprofloxacin and amoxicillin-clavulanate | 13 | 34 |
Quinolone alone | 11 | 29 |
Other | 14 | 37 |